Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10585-010-9346-8.

Title:
Involvement of Hepatopoietin Cn in the development of human hepatocellular carcinoma | Clinical & Experimental Metastasis
Description:
Hepatopoietin Cn (HPPCn) is a novel nuclear protein with the ability to promote liver regeneration. In the present study, we investigated the expression profile of HPPCn and its functional activity in human hepatocellular carcinoma (HCC) cell line and tissue samples. HPPCn expression was detected in HCC cell lines and 54 paired HCC carcinomas by immunochemical staining and Western blotting. The functional activity of HPPCn in cell lines was evaluated by MTT and colony formation assays and with nude mouse model. The correlation of HPPCn expression with clinicopathological characteristics of 54 HCC patients was also analyzed. Our results showed that HPPCn protein was prominently located within the nuclei of hepatocytes and the expression level was evidently increased in HepG2 and Bel7402 cell lines compared with L02 normal hepatocytes. HPPCn silencing by small interfering RNA greatly suppressed HepG2 cell proliferation and colony formation capacity and the inhibitory effect was also observed in a Balb/c-null mouse model. The silencing HPPCn expression effectively enhanced the apoptosis of HepG2 cells. In addition, HPPCn expression was detected in 48 of 54 (89%) human HCC tissues in sharp contrast with the corresponding non-tumor liver tissues. HPPCn protein was mainly accumulated in the tumor nucleus. The elevated expression of HPPCn protein in tumors was significantly associated with poor tumor cellular differentiation and present of vascular invasion. Patients with higher HPPCn expression in tumors had significantly shorter overall survival (OS) of both all of patients and the patients at the early stage. On multivariate Cox analysis, elevated expression of HPPCn in tumors was found to be an independent prognostic factor for OS. Therefore, these data suggest that HPPCn expression might be involved in the development of HCC and could be served as a promising biomarker.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Non-Profit & Charity

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We're unsure how the site profits.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {πŸ”}

article, google, scholar, pubmed, cas, hepatocellular, carcinoma, hppcn, expression, human, hepatopoietin, liu, cells, cancer, hcc, cell, analysis, cui, patients, beijing, privacy, cookies, content, research, tumor, factor, access, data, information, publish, search, metastasis, development, zhu, xiaoli, zhang, chunping, nuclear, protein, liver, hepg, prognosis, proteins, growth, staging, china, log, journal, clinical, experimental,

Topics {βœ’οΈ}

chun-ping cui balb/c-null mouse model rna-sequencing-based comparative analysis month download article/chapter serum alpha-fetoprotein levels growth factor signaling dong-dong zhang hcc cell lines leucine-rich repeats expressed proteins human hepatocellular carcinoma author information authors solitary hepatocellular carcinoma recurrent hepatocellular carcinoma full article pdf independent prognostic factor expression profile related proliferation myeloid leukemic cells jun ren xiao-li li privacy choices/manage cookies human hcc tissues nude mouse model article zhu leucine-rich repeats cell lines tumor growth hepatocellular carcinoma oncogene 25 human prostate cancer cell line check access instant access european economic area hepatopoietin cn colony formation assays colony formation capacity multivariate cox analysis american joint committee el naga ga nuclear factor murine cerebellar neuron centimeters complicating cirrhosis peking university school tumor liver tissues hepg2 cells promote liver regeneration liver injury induced conditions privacy policy

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Involvement of Hepatopoietin Cn in the development of human hepatocellular carcinoma
         description:Hepatopoietin Cn (HPPCn) is a novel nuclear protein with the ability to promote liver regeneration. In the present study, we investigated the expression profile of HPPCn and its functional activity in human hepatocellular carcinoma (HCC) cell line and tissue samples. HPPCn expression was detected in HCC cell lines and 54 paired HCC carcinomas by immunochemical staining and Western blotting. The functional activity of HPPCn in cell lines was evaluated by MTT and colony formation assays and with nude mouse model. The correlation of HPPCn expression with clinicopathological characteristics of 54 HCC patients was also analyzed. Our results showed that HPPCn protein was prominently located within the nuclei of hepatocytes and the expression level was evidently increased in HepG2 and Bel7402 cell lines compared with L02 normal hepatocytes. HPPCn silencing by small interfering RNA greatly suppressed HepG2 cell proliferation and colony formation capacity and the inhibitory effect was also observed in a Balb/c-null mouse model. The silencing HPPCn expression effectively enhanced the apoptosis of HepG2 cells. In addition, HPPCn expression was detected in 48 of 54 (89%) human HCC tissues in sharp contrast with the corresponding non-tumor liver tissues. HPPCn protein was mainly accumulated in the tumor nucleus. The elevated expression of HPPCn protein in tumors was significantly associated with poor tumor cellular differentiation and present of vascular invasion. Patients with higher HPPCn expression in tumors had significantly shorter overall survival (OS) of both all of patients and the patients at the early stage. On multivariate Cox analysis, elevated expression of HPPCn in tumors was found to be an independent prognostic factor for OS. Therefore, these data suggest that HPPCn expression might be involved in the development of HCC and could be served as a promising biomarker.
         datePublished:2010-08-04T00:00:00Z
         dateModified:2010-08-04T00:00:00Z
         pageStart:571
         pageEnd:580
         sameAs:https://doi.org/10.1007/s10585-010-9346-8
         keywords:
            Hepatopoietin Cn
            Hepatocellular carcinoma
            Cell proliferation
            Prognosis
            Cancer Research
            Biomedicine
            general
            Oncology
            Hematology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig6_HTML.gif
         isPartOf:
            name:Clinical & Experimental Metastasis
            issn:
               1573-7276
               0262-0898
            volumeNumber:27
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Bu-Dong Zhu
               affiliation:
                     name:Beijing Cancer Hospital & Institute
                     address:
                        name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiao-Li Li
               affiliation:
                     name:Beijing Institute of Radiation Medicine
                     address:
                        name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                        type:PostalAddress
                     type:Organization
                     name:Beijing 309 Hospital
                     address:
                        name:Beijing 309 Hospital, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yong Liu
               affiliation:
                     name:Beijing Institute of Radiation Medicine
                     address:
                        name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jing Chang
               affiliation:
                     name:Beijing Institute of Radiation Medicine
                     address:
                        name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yang Liu
               affiliation:
                     name:Beijing Institute of Radiation Medicine
                     address:
                        name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dong-Dong Zhang
               affiliation:
                     name:Beijing Institute of Radiation Medicine
                     address:
                        name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qiang Wang
               affiliation:
                     name:Beijing 309 Hospital
                     address:
                        name:Beijing 309 Hospital, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jun Ren
               affiliation:
                     name:Beijing Cancer Hospital & Institute
                     address:
                        name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Chun-Ping Cui
               affiliation:
                     name:Beijing Institute of Radiation Medicine
                     address:
                        name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Involvement of Hepatopoietin Cn in the development of human hepatocellular carcinoma
      description:Hepatopoietin Cn (HPPCn) is a novel nuclear protein with the ability to promote liver regeneration. In the present study, we investigated the expression profile of HPPCn and its functional activity in human hepatocellular carcinoma (HCC) cell line and tissue samples. HPPCn expression was detected in HCC cell lines and 54 paired HCC carcinomas by immunochemical staining and Western blotting. The functional activity of HPPCn in cell lines was evaluated by MTT and colony formation assays and with nude mouse model. The correlation of HPPCn expression with clinicopathological characteristics of 54 HCC patients was also analyzed. Our results showed that HPPCn protein was prominently located within the nuclei of hepatocytes and the expression level was evidently increased in HepG2 and Bel7402 cell lines compared with L02 normal hepatocytes. HPPCn silencing by small interfering RNA greatly suppressed HepG2 cell proliferation and colony formation capacity and the inhibitory effect was also observed in a Balb/c-null mouse model. The silencing HPPCn expression effectively enhanced the apoptosis of HepG2 cells. In addition, HPPCn expression was detected in 48 of 54 (89%) human HCC tissues in sharp contrast with the corresponding non-tumor liver tissues. HPPCn protein was mainly accumulated in the tumor nucleus. The elevated expression of HPPCn protein in tumors was significantly associated with poor tumor cellular differentiation and present of vascular invasion. Patients with higher HPPCn expression in tumors had significantly shorter overall survival (OS) of both all of patients and the patients at the early stage. On multivariate Cox analysis, elevated expression of HPPCn in tumors was found to be an independent prognostic factor for OS. Therefore, these data suggest that HPPCn expression might be involved in the development of HCC and could be served as a promising biomarker.
      datePublished:2010-08-04T00:00:00Z
      dateModified:2010-08-04T00:00:00Z
      pageStart:571
      pageEnd:580
      sameAs:https://doi.org/10.1007/s10585-010-9346-8
      keywords:
         Hepatopoietin Cn
         Hepatocellular carcinoma
         Cell proliferation
         Prognosis
         Cancer Research
         Biomedicine
         general
         Oncology
         Hematology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-010-9346-8/MediaObjects/10585_2010_9346_Fig6_HTML.gif
      isPartOf:
         name:Clinical & Experimental Metastasis
         issn:
            1573-7276
            0262-0898
         volumeNumber:27
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Bu-Dong Zhu
            affiliation:
                  name:Beijing Cancer Hospital & Institute
                  address:
                     name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiao-Li Li
            affiliation:
                  name:Beijing Institute of Radiation Medicine
                  address:
                     name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                     type:PostalAddress
                  type:Organization
                  name:Beijing 309 Hospital
                  address:
                     name:Beijing 309 Hospital, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yong Liu
            affiliation:
                  name:Beijing Institute of Radiation Medicine
                  address:
                     name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jing Chang
            affiliation:
                  name:Beijing Institute of Radiation Medicine
                  address:
                     name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yang Liu
            affiliation:
                  name:Beijing Institute of Radiation Medicine
                  address:
                     name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dong-Dong Zhang
            affiliation:
                  name:Beijing Institute of Radiation Medicine
                  address:
                     name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qiang Wang
            affiliation:
                  name:Beijing 309 Hospital
                  address:
                     name:Beijing 309 Hospital, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jun Ren
            affiliation:
                  name:Beijing Cancer Hospital & Institute
                  address:
                     name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Chun-Ping Cui
            affiliation:
                  name:Beijing Institute of Radiation Medicine
                  address:
                     name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical & Experimental Metastasis
      issn:
         1573-7276
         0262-0898
      volumeNumber:27
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Beijing Cancer Hospital & Institute
      address:
         name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
         type:PostalAddress
      name:Beijing Institute of Radiation Medicine
      address:
         name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
         type:PostalAddress
      name:Beijing 309 Hospital
      address:
         name:Beijing 309 Hospital, Beijing, China
         type:PostalAddress
      name:Beijing Institute of Radiation Medicine
      address:
         name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
         type:PostalAddress
      name:Beijing Institute of Radiation Medicine
      address:
         name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
         type:PostalAddress
      name:Beijing Institute of Radiation Medicine
      address:
         name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
         type:PostalAddress
      name:Beijing Institute of Radiation Medicine
      address:
         name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
         type:PostalAddress
      name:Beijing 309 Hospital
      address:
         name:Beijing 309 Hospital, Beijing, China
         type:PostalAddress
      name:Beijing Cancer Hospital & Institute
      address:
         name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
         type:PostalAddress
      name:Beijing Institute of Radiation Medicine
      address:
         name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Bu-Dong Zhu
      affiliation:
            name:Beijing Cancer Hospital & Institute
            address:
               name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
               type:PostalAddress
            type:Organization
      name:Xiao-Li Li
      affiliation:
            name:Beijing Institute of Radiation Medicine
            address:
               name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
               type:PostalAddress
            type:Organization
            name:Beijing 309 Hospital
            address:
               name:Beijing 309 Hospital, Beijing, China
               type:PostalAddress
            type:Organization
      name:Yong Liu
      affiliation:
            name:Beijing Institute of Radiation Medicine
            address:
               name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
               type:PostalAddress
            type:Organization
      name:Jing Chang
      affiliation:
            name:Beijing Institute of Radiation Medicine
            address:
               name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
               type:PostalAddress
            type:Organization
      name:Yang Liu
      affiliation:
            name:Beijing Institute of Radiation Medicine
            address:
               name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
               type:PostalAddress
            type:Organization
      name:Dong-Dong Zhang
      affiliation:
            name:Beijing Institute of Radiation Medicine
            address:
               name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
               type:PostalAddress
            type:Organization
      name:Qiang Wang
      affiliation:
            name:Beijing 309 Hospital
            address:
               name:Beijing 309 Hospital, Beijing, China
               type:PostalAddress
            type:Organization
      name:Jun Ren
      affiliation:
            name:Beijing Cancer Hospital & Institute
            address:
               name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Chun-Ping Cui
      affiliation:
            name:Beijing Institute of Radiation Medicine
            address:
               name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
      name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
      name:Beijing 309 Hospital, Beijing, China
      name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
      name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
      name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
      name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
      name:Beijing 309 Hospital, Beijing, China
      name:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
      name:Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(96)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.2s.